Clinical Trial Update: A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy [Phase 2]

View source ↗

Summary

This document summarizes a completed Phase II trial evaluating cisplatin-docetaxel induction followed by concurrent 3-D conformal radiotherapy with weekly chemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Locally Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED